Ticagrelor versus clopidogrel in patients with acute coronary syndromes and diabetes mellitus
- VernacularTitle:替格瑞洛和氯吡格雷对急性冠脉综合征合并糖尿病患者的血小板抑制作用
- Author:
Caihong PAN
;
Zeping HU
;
Bangning WANG
- Publication Type:Journal Article
- Keywords:
ticagrelor;
clopidogrel;
acute coronary syndromes;
diabetes;
platelet function
- From:
Acta Universitatis Medicinalis Anhui
2015;50(9):1351-1353
- CountryChina
- Language:Chinese
-
Abstract:
Patients diagnosed to have acute coronary syndromes( ACS) were included in the study. All ACS patients were divided into non-diabetes group(40 cases) and diabetes group(80 cases) . Blood coagulation function was de-termined for all patients. In the diabetes group eighty patients were randomly divided into ticagrelor group (48 ca-ses) and clopidogrel group (32 cases) . After 5 days′treatment, platelet function was detected. Our study aimed to examine the effects of ticagrelor and clopidogrel on the platelet function.
